How to Draft a Compelling CMS Comment Letter

A compelling comment letter to the Centers for Medicare and Medicaid Services (CMS) can influence how a proposed policy is understood, debated and revised. It can give decision-makers evidence they have not considered, explain the consequences for patients and clinicians, and offer a practical alternative to the proposal as written.

For Australian readers, CMS rulemaking operates outside the national health system. CMS oversees Medicare, Medicaid and related federal programmes in the United States, while Australian access is shaped by Medicare Australia, the Pharmaceutical Benefits Scheme, state governments, private insurers and other bodies. The formal CMS process applies to people with a direct interest in US policy, but its evidence-gathering and advocacy techniques are equally useful for submissions to Australian regulators, departments and consultation processes.

Understand where a CMS comment goes

CMS comments are part of the US federal rulemaking system. Before submitting a letter, identify whether the policy is a proposed rule, a request for information or another formal consultation. The Federal Register notice establishes the comment deadline, docket reference, submission method and questions the agency wants stakeholders to address. A comment that ignores those details may be overlooked because it does not respond to the actual decision being considered.

The American College of Cardiology’s Campaign for Patient Access illustrates the value of coordinated submissions on physician fee schedule changes. Clinicians can explain how reimbursement affects staffing, service availability and continuity of care, while patients can describe the practical impact of longer waits or reduced access to cardiovascular services. The strongest comments connect these perspectives to the agency’s stated policy objectives.

Australian advocacy operates through a different framework. Medicare Australia administers public health coverage, the Pharmaceutical Benefits Scheme funds listed medicines, and the Therapeutic Goods Administration (TGA) regulates medicines and medical devices. Federal consultations are commonly associated with Canberra, while submissions about insurance, hospital access or workforce impacts may also require engagement with state agencies, private health insurers or local representatives.

The relevant differences are straightforward:

Element	CMS federal rulemaking	Australian public consultation
Main route	Federal Register notice and submission through regulations.gov	Relevant department or regulator consultation process
Policy scope	US Medicare, Medicaid and related federal programmes	Medicare Australia, PBS, TGA, private insurance or state health policy
Useful evidence	US beneficiary, clinician, practice and utilisation data	Australian outcomes, costs, workforce and access data
Public record	Comments are generally public; identify confidential material clearly	Submissions may be published; check the consultation’s privacy terms
Best approach	Respond directly to the proposed rule and its questions	Address the specific decision-maker and demonstrate local relevance

Read the proposal like a reviewer

Begin with the full proposed rule, not only the press release or summary. Read the sections on background, alternatives, economic analysis, equity impact and requested feedback. Note the proposed changes, the evidence CMS says it considered and any areas where its conclusions depend on assumptions that require testing.

Record the docket number, regulation identifier, publication date, deadline and time zone. CMS comments are generally submitted through regulations.gov, although the Federal Register notice contains the controlling instructions. Some consultations request information in a specific format or direct stakeholders to particular questions. A late or misdirected submission may not be considered.

Then separate CMS’s stated reasons from the commenter’s conclusions. For example, a fee schedule proposal might cite projected spending, budget neutrality or administrative burden. Your letter should examine whether those explanations reflect how cardiology practices actually operate. This creates a focused argument rather than a general objection to government policy.

Australian readers should avoid assuming that overseas experience automatically determines US policy. If evidence from Australia, the United Kingdom or another country is relevant, explain why its conditions are comparable and where they differ. Health financing, workforce distribution and patient expectations are shaped by local systems, so precise adaptation is stronger than broad claims that a policy “works elsewhere.”

Gather evidence and patient experience

Strong comments combine quantitative evidence with credible examples of patient impact. Relevant data may include appointment waiting times, hospital admission rates, travel distance, service closures, staffing levels, out-of-pocket costs and the effect of reimbursement on specialist participation. Use clearly identified sources and state whether figures describe one practice, a regional service or the entire US market.

Clinical evidence should be linked to the issue in the proposed rule. If a change could affect echocardiography, cardiac imaging, ambulatory treatment or access to urgent review, show the pathway from reimbursement to service availability. Avoid presenting association as causation, and identify any uncertainty. Decision-makers are more likely to reconsider a proposal when the commenter exposes a specific gap rather than offering a general complaint.

Patient stories add detail that cannot be captured in a spreadsheet, but they should support rather than replace evidence. Obtain consent, remove unnecessary identifiers and explain the relationship between the experience and the policy question. Submissions made publicly can expose personal information. If CMS offers a confidential-submission process, request it where appropriate and state why disclosure could cause harm.

Australian examples can illuminate access issues involving rural and remote patients, Aboriginal community-controlled health organisations, telehealth and regional referral networks. In large private hospital markets such as Sydney and Melbourne, affordability and insurer participation may also shape whether patients can choose a cardiologist. These examples are most persuasive when framed as lessons for CMS rather than as claims about Australian policy.

Build a persuasive argument

State the requested action early. A reader should understand within the first paragraph whether you support the proposal, oppose it, seek modifications or request more analysis. Identify the exact rulemaking using its title, docket number and relevant section. Avoid vague opening statements that could apply to almost any CMS consultation.

Develop a clear chain of reasoning: the proposed change creates a specific mechanism, that mechanism affects clinicians or patients, and the effect conflicts with the agency’s stated goals. This might involve a reduction in payment leading to reduced staffing, longer waits and delayed intervention. Support each step with evidence and acknowledge any counterargument. A balanced explanation makes the conclusion more credible.

Offer an alternative that can be evaluated. CMS may be able to phase in a change, limit its scope, preserve access for high-need patients, revise the economic assumptions or collect better data before implementation. Recommendations should be specific enough for policy staff and stakeholders to assess. “Consider further study” is less useful than “extend the transition period for rural hospitals to 24 months and publish quarterly utilisation data.”

Quantify the proposed remedy where possible. Explain how many services or patients are affected, which groups face the greatest risk and what resources would be required. Australian cost comparisons should identify the currency, reference year and source. If converting US dollar amounts to Australian dollars, make clear that the exchange rate is illustrative rather than evidence of an Australian financial impact.

Write the letter with precision

Use a professional subject line such as “Stakeholder comments on [Proposed Rule Title], CMS-[Docket Number]”. Address the letter to the CMS Administrator, the relevant deputy administrator or the official named in the notice. The opening paragraph should identify the commenter, relevant expertise and core request. Readers should not have to infer why the organisation is qualified to comment.

Keep sentences direct and paragraphs purposeful. Federal rulemaking can attract lengthy submissions, so each paragraph should advance one argument. Use plain English alongside necessary technical terms. Terms such as reimbursement, physician fee schedule, beneficiary access, utilisation, workforce capacity and health equity can help reviewers connect the comment to the issues in the proposal.

Avoid hyperbole and partisan language. Instead of saying a policy will destroy cardiovascular care, state which services could be withdrawn, how many patients could be affected and when the impact would occur. Likewise, distinguish firsthand evidence from information supplied by another organisation. Attribute quotations, statistics and clinical claims so reviewers can verify them.

A practical letter usually progresses from the position and supporting evidence to the proposed remedy. A concise concluding paragraph can restate the requested action, explain why it is achievable and identify the evidence that should accompany the agency’s decision. This structure respects the decision-making process while keeping the commenter’s position visible throughout.

Review and submit the comment

Check every factual claim against its source and verify names, titles, dates, dollar amounts and references. Ask a colleague outside the organisation to read the draft for clarity. A reviewer who understands the issue but not the background should be able to identify the problem, evidence and requested change without needing the original proposal.

Protect privacy before submission. Remove names, dates of birth, medical record numbers and other direct identifiers from narratives unless they are essential and properly protected. Be cautious with screenshots, patient correspondence and documents downloaded from clinical systems. Metadata can also reveal identifying information, so review attachments as carefully as the main letter.

Submit through the method specified in the Federal Register notice, commonly regulations.gov, and save the confirmation or electronic receipt. Keep a copy of the exact version submitted, the docket number and supporting files. Once the deadline passes, monitor the agency’s website for the final rule, response to comments and any announcement of additional review.

Australian contributors who need to influence CMS should document their US connection clearly, such as involvement in American research, clinical services, manufacturing or patient care. Those submitting to an Australian body should follow the local consultation process, retain proof of delivery and check whether the agency publishes submissions. The expectation of transparent public records is familiar across both systems, even though the agencies and legal requirements differ.

Turn the letter into effective action

Use this checklist to strengthen the final draft:

• Verify the docket, deadline, time zone and submission instructions against the original notice.
• State the position and requested action in the opening paragraph.
• Attach each major claim to a reliable source or a clearly described patient experience.
• Quantify patient, workforce, service and financial effects wherever credible data allow.
• Propose a practical alternative and explain how CMS could evaluate it.
• Remove personal identifiers, proofread the attachments and retain submission confirmation.

Choose one active CMS consultation and make its proposed rule the next document reviewed. Identify the specific decision that requires support, gather evidence from patients and cardiovascular professionals, and submit a comment that asks for a clear and workable change. Australian advocates can apply the same discipline to consultations on the PBS, private insurance, medicines regulation or rural health access.